Articles

A Year in Neurology

Multiple Sclerosis In multiple sclerosis (MS), 2008 has been a big year in terms of diseasemodifying therapies. Results from key clinical trials...

As Use of Herbal Remedies Soars, Patients Taking These and Cardiovascular Medications May be at Heightened Risk of Dangerous, Potentially Life-Threatening Interactions

"Many people have a false sense of security about these herbal products because they are seen as 'natural,'" said Arshad Jahangir, M.D.,...

Developing Classification in Psychiatry - Implications of 50 Years of Progress in Psychopharmacological Therapeutics

With the criteria set out by Robins and Guze,3 psychiatry felt confident of validating its diagnostic groupings and refining the relationship...

Functional Magnetic Resonance Imaging – Implications for Detection of Schizophrenia

Functional magnetic resonance imaging (fMRI) is a fairly new tool that has been used to measure brain activation utilising the dependency of the...

Mayo Clinic Researchers Show Brain Waves Can "Write" on a Computer in Early Tests

Researchers say these findings, presented at the 2009 annual meeting of the American Epilepsy Society, represent concrete progress toward a ...

Pharmacological Treatment of Schizophrenia

Cognitive impairment and deterioration are core features of schizophrenia and they are strongly related to disability. Short History of...

Progress in Pharmacopsychiatry

After more than 40 years of clinical practice with the traditional neuroleptics, several more or less generally accepted rules for the management of...

Regulating Stem Cell Research in Europe

Thus far, the patients the people for whom these matters hold most importance have not been involved. This means that a number of decisions have...

Schizophrenia-like psychosis following left putamen infarct: a case report

Introduction The basal ganglia and cerebellum have been extensively studied in schizophrenia as these areas of the brain are involved in the control...

The Neurology Arena In Brief - A Round-up of Trends, Statistics and Clinical Research

The GPDS questioned more than 1,900 physicians, PD patients and care-givers about how the disease affected them. It found that around half of PD...

Tryptophan Metabolism as a New Target for the Treatment of Schizophrenia

Kynurenine is further metabolized along two distinct routes: the kynurenine–kynurenic acid (KYNA) pathway, regulated by kynurenine amino...

US Food and Drug Administration Medical Device Research Considerations

The same basic regulations from the US Code of Federal Regulations (CFR) apply to all clinical investigations of medical devices. These include 21...

Why Are Children and Adolescents with 22q11.2 Deletion Syndrome at High Risk of Developing Schizophrenia?

These initial efforts were followed by a larger study involving 50 adults affected with 22q11DS.1 The complete psychiatric evaluations performed with...

Copyright® 2012 Touch Group PLC. All rights reserved.
Touch Neurology is for informational purposes and should not be considered medical advice, diagnosis or treatment recommendations.